Phocas Financial »

Nurix Therapeutics shares owned by Phocas Financial

Quarter-by-quarter ownership of Nurix Therapeutics (NRIX) shares owned by Phocas Financial from 13F filings

Historical chart of Phocas Financial investment in Nurix Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nurix Therapeutics held by Phocas Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nurix Therapeutics by Phocas Financial

Quarter filed Position value Share count Share price at filing
2026-06-30 $2.4M 100k 24.26

More positions owned by Phocas Financial

Ducommun Incorporated (DCO)
Amneal Pharmaceuticals Com Stk Cl A (AMRX)
Aar (AIR)
Materion Corporation (MTRN)
Stonex Group (SNEX)
Ralliant Corp (RAL)
Wintrust Financial Corporation (WTFC)
National Energy Services Reu SHS (NESR)
Ameris Ban (ABCB)
Columbia Banking System (COLB)
Alerus Finl (ALRS)
Meta Financial (CASH)
Carpenter Technology Corporation (CRS)
SkyWest (SKYW)
Preferred Bk Los Angeles Ca Com New (PFBC)

View all positions for Phocas Financial

Top funds holding Nurix Therapeutics

BlackRock
Redmile Group
Vestal Point Capital
Deep Track Capital
FMR
State Street Corporation
Morgan Stanley
Baker Bros. Advisors
Vanguard Capital Management
General Atlantic
Perceptive Advisors
T. Rowe Price Associates
Geode Capital Management
Rubric Capital Management
Pictet Asset Management Holding SA

View all funds holding Nurix Therapeutics